NCT05842343

Brief Summary

Anorexia nervosa is characterized by intestinal dysbiosis, related to the feeding behavior impairment presented by these patients. Pathophysiologic hypotheses are involving the trouble of the microbiota-gut-brain axis in the field of mental diseases.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

October 13, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2024

Completed
Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

April 24, 2023

Last Update Submit

November 21, 2025

Conditions

Keywords

anorexia nervosamicrobiotagut-brain-axisimmunology (IgA)

Outcome Measures

Primary Outcomes (1)

  • Total microbiotic profile

    abundance and diversity parameters of the IgA microbiota fraction of the intestinal microbiota obtained by 16s rDNA analysis of stool suspension samples from acute anorexia nervosa, chronic anorexia nervosa and control subjects.

    1 week after inclusion

Secondary Outcomes (3)

  • ELISA assay of fecal immunoglobulins

    1 week after inclusion

  • Microbiotic profile of total intestinal microbiota

    1 week after inclusion

  • Food intake characteristics

    1 week after inclusion

Study Arms (3)

Acute anorexia nervosa

EXPERIMENTAL

patient diagnose for a first episode of pure restrictive anorexia nervosa will be included. They will have stool sample and Food intake evaluation.

Other: Stool sampleOther: Food intake evaluation

Chronic anorexia nervosa

EXPERIMENTAL

Patient diagnose for anorexia nervosa at least 5 years ago and still maintaining a significant thinness will be included. They will have stool sample and Food intake evaluation.

Other: Stool sampleOther: Food intake evaluation

Healthy control

PLACEBO COMPARATOR

Healthy Patient will be included. They will have stool sample and Food intake evaluation.

Other: Stool sampleOther: Food intake evaluation

Interventions

Purification by affinity of the IgA coated bacteria from a fecal solution. Genomic analysis of the bacteria for diversity and richness

Acute anorexia nervosaChronic anorexia nervosaHealthy control

Measure (by survey) of food group intake for : lipids /proteins / fibers / carbohydrates

Acute anorexia nervosaChronic anorexia nervosaHealthy control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female subject, adult, affiliated to a social security system, under the care of the eating disorder department of university hospital of st Etienne
  • presenting a diagnosis of pure restrictive anorexia nervosa.
  • For acute subgroup : BMI between 11 and 17.5 kg/m2, patient with a first episode of restrictive anorexia nervosa or with hyperphagic episodes.
  • For the chronic subgroup: BMI between 11 and 17.5 kg/m2, disease evolving for more than 5 years.
  • For Healthy volunteer: BMI between 20 and 24 kg/m², stable weight for the last 3 months, no eating disorder or history of eating disorder

You may not qualify if:

  • patient does not understand French.
  • laxative treatment in progress or stopped for less than 15 days,
  • patient with one of the following comorbid disorders: celiac disease, chronic inflammatory bowel disease, lactose intolerance, unstabilized hyperthyroidism, unstabilized diabetes,
  • subject under legal protective measures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • Tristan GABRIEL-SEGARD, Md

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2023

First Posted

May 6, 2023

Study Start

October 13, 2023

Primary Completion

November 28, 2023

Study Completion

February 2, 2024

Last Updated

November 26, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations